CVS Health Corporation (CVS): Price and Financial Metrics


CVS Health Corporation (CVS)

Today's Latest Price: $71.78 USD

0.22 (-0.31%)

Updated Feb 19 6:40pm

Add CVS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 3 in Medical - Drug Stores

See all "A" rated Strong Buy stocks

CVS Stock Summary

  • CVS has a higher market value than 97.91% of US stocks; more precisely, its current market capitalization is $97,923,560,807.
  • The capital turnover (annual revenue relative to shareholder's equity) for CVS is 3.91 -- better than 87.3% of US stocks.
  • CVS's went public 34.16 years ago, making it older than 92.48% of listed US stocks we're tracking.
  • Stocks that are quantitatively similar to CVS, based on their financial statements, market capitalization, and price volatility, are UPS, MO, LOW, GE, and AXP.
  • CVS's SEC filings can be seen here. And to visit CVS HEALTH Corp's official web site, go to www.cvshealth.com.
CVS Daily Price Range
CVS 52-Week Price Range

CVS Stock Price Chart More Charts


CVS Price/Volume Stats

Current price $71.78 52-week high $77.03
Prev. close $72.00 52-week low $51.72
Day low $71.66 Volume 4,831,600
Day high $72.56 Avg. volume 7,016,694
50-day MA $72.94 Dividend yield 2.79%
200-day MA $63.87 Market Cap 93.38B

CVS Health Corporation (CVS) Company Bio


CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.

CVS Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$71.78$167.64135%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for CVS HEALTH Corp. To summarize, we found that CVS HEALTH Corp ranked in the 75st percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 136%. In terms of the factors that were most noteworthy in this DCF analysis for CVS, they are:

  • The company has produced more trailing twelve month cash flow than 96.74% of its sector Healthcare.
  • 51% of the company's capital comes from equity, which is greater than just 21.24% of stocks in our cash flow based forecasting set.
  • CVS HEALTH Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 4.36% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%130%
1%133%
2%135%
3%137%
4%139%
5%142%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CVS, try AGN, CI, JAZZ, XTNT, and DYNT.


CVS Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CVS Latest Social Stream


Loading social stream, please wait...

View Full CVS Social Stream

CVS Price Returns

1-mo -3.12%
3-mo -4.04%
6-mo 20.87%
1-year 15.49%
3-year -1.64%
5-year -21.04%
YTD -2.73%
2019 17.26%
2018 -7.04%
2017 -5.75%
2016 -17.83%
2015 2.90%

CVS Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full CVS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7343 seconds.